Bio-Techne (TECH) Misses Q4 EPS by 3c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Bio-Techne Corp. (TECH) PT Lowered to $500 at Stifel
August 4, 2022 3:52 PM EDTStifel analyst Daniel Arias lowered the price target on Bio-Techne Corp. (NASDAQ: TECH) to $500.00 (from $560.00) while maintaining a Buy rating following results.
The analyst commented, "TECH's finish to fiscal 2022 was solid, and marked by 14% organic that brought FY22 to 16%. Looking to FY23, mgmt's... More
